This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
Take it with you! CLL Society’s Official COVID-19 Triage Statement
CLL Society has authored an Official Statement to help you help your healthcare providers understand CLL patients’ unique vulnerabilities to COVID-19 and our higher risks of serious complications.
This letter to your healthcare provider may help you be attended to faster, should you have any COVID-19 symptoms or worries. It also reminds providers of the possible benefits of timely administration of one of the authorized SARS-CoV-2 monoclonal antibodies to prevent serious illness or hospitalization, or the early use of high titer convalescent plasma in hospital.
COVID-19 concerns are topline in medical settings these days and the demands for care can overwhelm some medical facilities, so triaging who gets attention and more intensive management becomes a necessity. Fax, email, or otherwise draw your provider’s attention to this letter!
The CLL Society is invested in your long life. Please invest in the long life of the CLL Society.